We recently published 10 Stocks With Massive Gains; 5 at Record Highs. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) was one ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...

In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.70, marking a -3.29% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.

2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...

Telsa CEO Elon Musk stated that humanoid robots will replace surgeons within three years, declaring, “Going to medical school is meaningless.” Musk made the remarks on the 8th while appearing on ...

On a Tuesday at the end of last semester, I asked my first-year writing class how they were using AI in their courses. One of ...

Carrillo’s promotion reflects Menlo Ventures’ commitment to strengthening its leadership bench and supporting the firm’s long ...

Nkembuh, N. (2026) Symbiotic Communication Systems: Examining the Co-Evolution of Human-AI Communication Patterns in the ...

Between Choice and Fate at Batsford Gallery has a very charged yet subtle quality. The gallery’s atmosphere seems more akin ...

In addition to being early to the defense tech and AI trends, Lux has realized significant exits from its investment in AI ...